HI HCR147

Urges the U.S. Food and Drug Administration to expedite approval of new nonprescription sunscreen active ingredients that have been used globally and are covered by pending Time and Extent Applications from the sunscreen industry

Notes that the FDA has not approved any pending applications for nonprescription sunscreen active ingredients despite their demonstrated safe and effective use globally

States that the delay in FDA approval has hindered the sunscreen industry's ability to innovate and bring alternative ingredients to the U.S. market

Requests the FDA work collaboratively with stakeholders to approve ingredients that provide consumers with more sunscreen product options while enabling industry innovation

Directs certified copies of the resolution be transmitted to the FDA Commissioner, congressional leadership, Hawaii's congressional delegation, and presiding officers of all state legislative bodies